According to a new market research study titled ‘PACS and RIS Market to 2027 – Global Analysis and Forecasts by Product, Component, Deployment, and End User.’ The Global PACS and RIS Market is expected to reach US$ 5,008.93 Mn in 2027 from US$ 2,728.43 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027. The report highlights the trends prevalent in the global PACS and RIS market and the factors driving the market along with those that act as deterrents to its growth.
Global PACS and RIS market, based on the product, was segmented as, Picture archiving and communication system (PACS) and radiology information system (RIS). In 2018, PACS held the largest share of the market, by product. In addition, the segment is also anticipated to grow at a significant rate during the forecast period. The solution offers benefits such as improved viewing and analysis, easy access to images and other reports, efficient data management as well as a user-friendly interface, these factors are anticipated to lead to the growth of the segment during the forecast period.
Get sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00003005/
The market for PACS and RIS is expected to grow, owing to factors such as developments in diagnostic imaging modalities coupled with the rising number of diagnostic tests procedures, affordable price of new generation PACS software and new product launches & FDA approvals. In addition, increasing demand for orthopaedic PACS likely to have a positive impact on the growth of the market in the coming years.
The major players operating in the PACS and RIS market include, McKesson Corporation, General Electric, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Siemens AG, Cerner Corporation, IBM, Novarad, Agfa-Gevaert Group, and INFINITT Healthcare Co., Ltd. The market has witnessed various organic as well as inorganic developments during recent years in the PACS and RIS market. During September 2018, Novarad Corporation entered into a contract with Brown University Health Services to provide PACS and RIS software. The solution offers enhanced control over study information as well as an increased capacity for care both inside as well as outside of the facility, especially while referring physicians. These properties have led to increased adoption of the solution among the customers.
Medical imaging is a vital part in medical care and treatment across the globe. Rising awareness regarding early diagnosis of diseases has led to an increase in the total number of diagnostic tests procedures performed around the world. During the year 2012, Canadians underwent 1.7 million magnetic resonance imaging (MRI) exams and 4.4 million computed tomographies (CT) exams. The statistics reveal, nearly double the number of such reviews performed during 2003. The national rate for CT scans were 126 per 1,000 individuals around 2014 and 2015. Rates ranged from 209 (New Brunswick) and 170 (Newfoundland and Labrador) to 88 (Alberta) and 93 (Prince Edward Island). In addition, according to the National Health Services (NHS) UK, there were 4.1 million imaging tests conducted in England in the 12 months from February 2016 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017.
The global PACS and RIS market by product was led by PACS segment. In 2018, the segment of held the largest market share in the PACS and RIS market, by product. The segment is also expected to witness growth at a significant rate during the forecast period, as the solution offers benefits such as improved viewing and analysis, easy access to images and other reports, efficient data management
Purchase This Report @ https://www.theinsightpartners.com/buy/TIPRE00003005/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.